EA200970002A1 - Двойственные молекулы, содержащие пероксидное производное, их синтез и их терапевтические применения - Google Patents
Двойственные молекулы, содержащие пероксидное производное, их синтез и их терапевтические примененияInfo
- Publication number
- EA200970002A1 EA200970002A1 EA200970002A EA200970002A EA200970002A1 EA 200970002 A1 EA200970002 A1 EA 200970002A1 EA 200970002 A EA200970002 A EA 200970002A EA 200970002 A EA200970002 A EA 200970002A EA 200970002 A1 EA200970002 A1 EA 200970002A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- group
- mixtures
- mean
- hydrogen atom
- synthesis
- Prior art date
Links
- 230000009977 dual effect Effects 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 150000002978 peroxides Chemical class 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 230000000078 anti-malarial effect Effects 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- -1 cyclic peroxide Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000000524 functional group Chemical group 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 125000003367 polycyclic group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 abstract 1
- 125000006168 tricyclic group Chemical group 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Изобретение относится к двойственным молекулам, отвечающим формуле (I), в которой А означает остаток молекулы с противомалярийной активностью формул (IIa) или (IIIa) или облегчающий биодоступность остаток; В означает возможно замещенную циклоалкильную группу или В означает би- или трициклическую группу, которая может быть замещена, или же В означает 2 циклоалкильные группы, связанные между собой ординарной связью или алкиленовой цепью; m и n, независимо друг от друга, означают 0, 1 или 2; Rозначает атом водорода, алкильную группу, циклоалкильную группу или C-алкиленциклоалкильную группу; Zи Zозначают алкиленовый радикал, причем совокупность Z+Z+C+Cозначает моно- или полициклическую структуру, и причем Zили Zможет означать ординарную связь; Rи R, одинаковые или разные, означают атом водорода или функциональную группу, способную повышать водорастворимость; Rи Rвместе образуют циклический пероксид, включающий 4-8 звеньев и содержащий 1 или 2 дополнительных атома кислорода в циклической структуре, возможно замещенный одной или несколькими группами R; в виде основания или аддитивной соли кислоты, в виде гидрата или сольвата, в рацемической форме, в форме изомеров и их смесей, а также их диастереоизомеров и их смесей; способу получения и применению в качестве лекарственных средств с противомалярийной активностью.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0605235A FR2902100A1 (fr) | 2006-06-13 | 2006-06-13 | Molecules duales contenant un derive peroxydique, leur synthese et leurs applications en therapeutique |
PCT/FR2007/000946 WO2007144487A2 (fr) | 2006-06-13 | 2007-06-08 | Molecules duales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200970002A1 true EA200970002A1 (ru) | 2009-06-30 |
Family
ID=37719816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200970002A EA200970002A1 (ru) | 2006-06-13 | 2007-06-08 | Двойственные молекулы, содержащие пероксидное производное, их синтез и их терапевтические применения |
Country Status (24)
Country | Link |
---|---|
US (1) | US20120122923A1 (ru) |
EP (1) | EP2032561A2 (ru) |
JP (1) | JP2009539946A (ru) |
KR (1) | KR20090029208A (ru) |
CN (1) | CN101466706A (ru) |
AP (1) | AP2008004711A0 (ru) |
AR (1) | AR061347A1 (ru) |
AU (1) | AU2007259116A1 (ru) |
BR (1) | BRPI0713739A2 (ru) |
CA (1) | CA2665940A1 (ru) |
CR (1) | CR10469A (ru) |
EA (1) | EA200970002A1 (ru) |
EC (1) | ECSP088958A (ru) |
FR (1) | FR2902100A1 (ru) |
IL (1) | IL195394A0 (ru) |
MA (1) | MA30577B1 (ru) |
MX (1) | MX2008015980A (ru) |
NO (1) | NO20085308L (ru) |
PE (1) | PE20080335A1 (ru) |
TN (1) | TNSN08462A1 (ru) |
TW (1) | TW200817376A (ru) |
UY (1) | UY30413A1 (ru) |
WO (1) | WO2007144487A2 (ru) |
ZA (1) | ZA200810012B (ru) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2924343A1 (fr) * | 2007-12-04 | 2009-06-05 | Palumed Sa | Nouvelles utilisations therapeutiques de molecules duales contenant un derive peroxydique. |
AU2012225735B2 (en) | 2011-03-04 | 2016-03-10 | Glaxosmithkline Intellectual Property Development Limited | Amino-quinolines as kinase inhibitors |
TWI547494B (zh) | 2011-08-18 | 2016-09-01 | 葛蘭素史克智慧財產發展有限公司 | 作為激酶抑制劑之胺基喹唑啉類 |
TWI592417B (zh) | 2012-09-13 | 2017-07-21 | 葛蘭素史克智慧財產發展有限公司 | 胺基喹唑啉激酶抑制劑之前藥 |
TW201425307A (zh) | 2012-09-13 | 2014-07-01 | Glaxosmithkline Llc | 作為激酶抑制劑之胺基-喹啉類 |
KR20150118152A (ko) | 2013-02-21 | 2015-10-21 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | 키나제 억제제로서의 퀴나졸린 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2133620A1 (en) * | 1993-10-28 | 1995-04-29 | Werner Hofheinz | Aminoquinoline derivatives |
TR199800854T2 (xx) * | 1995-11-16 | 1998-08-21 | F.Hoffmann-La Roche Ag | Antis�tma kinolin t�revleri. |
PL343680A1 (en) * | 1998-04-29 | 2001-08-27 | Smithkline Beecham Plc | Quinolones used as mrs inhibitors and bactericides |
FR2807433B1 (fr) * | 2000-04-06 | 2002-09-20 | Centre Nat Rech Scient | Molecules duales contenant un derives peroxydique, leur synthese et leurs applications therapeutiques |
US6486199B1 (en) * | 2001-06-21 | 2002-11-26 | Medicines For Malaria Venture Mmv International Centre Cointrin | Spiro and dispiro 1,2,4-trioxolane antimalarials |
WO2003070244A1 (en) * | 2002-02-22 | 2003-08-28 | Abbott Laboratories | Antagonist of melanin concentrating hormone and their uses |
SE0202134D0 (sv) * | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Therapeutic agents |
US20050256157A1 (en) * | 2002-08-23 | 2005-11-17 | Chiron Corporation | Combination therapy with CHK1 inhibitors |
CA2496164C (en) * | 2002-08-23 | 2010-11-09 | Chiron Corporation | Benzimidazole quinolinones and uses thereof |
US20050197350A1 (en) * | 2003-03-31 | 2005-09-08 | Taisho Pharmaceutical Co., Ltd. | Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof |
HU227684B1 (en) * | 2003-08-29 | 2011-11-28 | Sanofi Aventis | Adamantane and azabicyclo-octane and nonane derivatives and their use as dpp-iv inhibitors |
FR2862304A1 (fr) * | 2003-11-14 | 2005-05-20 | Centre Nat Rech Scient | Molecules duales racemiques ou achirales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques |
EP1706384A1 (en) * | 2004-01-07 | 2006-10-04 | AstraZeneca AB | Therapeutic agents i |
CA2571360C (en) * | 2004-06-18 | 2014-11-25 | 3M Innovative Properties Company | Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines useful in inducing cytokine biosynthesis in animals |
FR2889525A1 (fr) * | 2005-08-04 | 2007-02-09 | Palumed Sa | Nouveaux derives de polyquinoleines et leur utilisation therapeutique. |
-
2006
- 2006-06-13 FR FR0605235A patent/FR2902100A1/fr not_active Withdrawn
-
2007
- 2007-06-08 CN CNA2007800218550A patent/CN101466706A/zh active Pending
- 2007-06-08 CA CA002665940A patent/CA2665940A1/fr not_active Abandoned
- 2007-06-08 AU AU2007259116A patent/AU2007259116A1/en not_active Abandoned
- 2007-06-08 WO PCT/FR2007/000946 patent/WO2007144487A2/fr active Application Filing
- 2007-06-08 JP JP2009514836A patent/JP2009539946A/ja not_active Withdrawn
- 2007-06-08 KR KR1020087030376A patent/KR20090029208A/ko not_active Application Discontinuation
- 2007-06-08 MX MX2008015980A patent/MX2008015980A/es active IP Right Grant
- 2007-06-08 BR BRPI0713739-7A patent/BRPI0713739A2/pt not_active IP Right Cessation
- 2007-06-08 ZA ZA200810012A patent/ZA200810012B/xx unknown
- 2007-06-08 EP EP07788851A patent/EP2032561A2/fr not_active Withdrawn
- 2007-06-08 EA EA200970002A patent/EA200970002A1/ru unknown
- 2007-06-08 AP AP2008004711A patent/AP2008004711A0/xx unknown
- 2007-06-12 PE PE2007000739A patent/PE20080335A1/es not_active Application Discontinuation
- 2007-06-12 AR ARP070102553A patent/AR061347A1/es not_active Application Discontinuation
- 2007-06-13 UY UY30413A patent/UY30413A1/es not_active Application Discontinuation
- 2007-06-13 TW TW096121347A patent/TW200817376A/zh unknown
-
2008
- 2008-11-17 TN TNP2008000462A patent/TNSN08462A1/en unknown
- 2008-11-19 IL IL195394A patent/IL195394A0/en unknown
- 2008-11-27 CR CR10469A patent/CR10469A/es not_active Application Discontinuation
- 2008-12-11 EC EC2008008958A patent/ECSP088958A/es unknown
- 2008-12-11 US US12/332,633 patent/US20120122923A1/en not_active Abandoned
- 2008-12-18 NO NO20085308A patent/NO20085308L/no not_active Application Discontinuation
-
2009
- 2009-01-06 MA MA31552A patent/MA30577B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
AU2007259116A8 (en) | 2009-04-30 |
AR061347A1 (es) | 2008-08-20 |
PE20080335A1 (es) | 2008-05-22 |
NO20085308L (no) | 2009-03-12 |
MA30577B1 (fr) | 2009-07-01 |
KR20090029208A (ko) | 2009-03-20 |
CR10469A (es) | 2009-02-26 |
TNSN08462A1 (en) | 2010-04-14 |
CA2665940A1 (fr) | 2007-12-21 |
MX2008015980A (es) | 2009-03-26 |
ECSP088958A (es) | 2009-01-30 |
CN101466706A (zh) | 2009-06-24 |
AU2007259116A1 (en) | 2007-12-21 |
IL195394A0 (en) | 2009-08-03 |
AP2008004711A0 (en) | 2008-12-31 |
BRPI0713739A2 (pt) | 2013-06-18 |
FR2902100A1 (fr) | 2007-12-14 |
TW200817376A (en) | 2008-04-16 |
WO2007144487A3 (fr) | 2008-02-07 |
UY30413A1 (es) | 2008-01-31 |
US20120122923A1 (en) | 2012-05-17 |
WO2007144487A2 (fr) | 2007-12-21 |
JP2009539946A (ja) | 2009-11-19 |
EP2032561A2 (fr) | 2009-03-11 |
ZA200810012B (en) | 2010-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR083070A1 (es) | Analogos de nucleotidos sustituidos con heterociclos nitrogenados, composiciones farmaceuticas que los contienen y uso de los mismos para tratar enfermedades virales, en particular infecciones por vhc | |
CO5580815A2 (es) | Derivados de adamantana, procesos para su preparacion y composiciones farmaceuticas que los contienen | |
EA200970002A1 (ru) | Двойственные молекулы, содержащие пероксидное производное, их синтез и их терапевтические применения | |
CY1117576T1 (el) | Δινουκλεοτιδικα προφαρμακα | |
AR044874A1 (es) | Derivados de 4- cianopirazol-3 - carboxamida, su preparacion y su aplicacion en terapeutica | |
ECSP088253A (es) | Derivados de azol y tiazol y sus usos | |
AR083069A1 (es) | Analogos de nucleotidos sustituidos | |
RU2015148010A (ru) | Высокоактивное производное нуклеозида для лечения hcv | |
EA200701176A1 (ru) | Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их | |
AR086357A1 (es) | Derivados de indazol sustituidos activos como inhibidores de quinasas | |
AR077505A1 (es) | Compuestos de piridina y sus usos | |
CO6300865A2 (es) | Derivados polisustituidos de 2 aril-6-fenil-imidazo[1,2-a]piridinas su preparacion y su aplicacion en terapeutica | |
UY30130A1 (es) | Derivados de n-heteroaril-carboxamidas triciclicas que contienen un resto bencimidazol, su preparacion y su aplicacion en terapeutica. | |
AR046711A1 (es) | 5-7-diaminopirazolo[4,3d]pirimidinas como inhibidores de la pde-5,composiciones farmaceuticas que las contienen y usos en el tratamiento de hipertensiones | |
CR7950A (es) | Sintesis de los cloruros de 4amino -2butenoilo y su uso en la preparacion of 3- cianoquinolinas | |
EA201001595A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
AR058073A1 (es) | Derivados de imidazol 5-il-pirimidina, procesos de obtencion, composiciones farmaceuticas y usos | |
PE20061054A1 (es) | Derivados de l- leucinamida como inhibidores de cisteinproteasas | |
ES2525353T3 (es) | Derivado de espiroimidazolona | |
TW200800962A (en) | Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions | |
CO6210724A2 (es) | Compuesto heterociclico y composicion farmaceutica del mismo | |
AR054790A1 (es) | Metodos para el tratamiento de disfuncion sexual | |
AR087302A1 (es) | Derivados aza heterociclicos sustituidos | |
MX2010002662A (es) | Aminoquinolonas espirociclicas como inhibidores de gsk-3. | |
AR056194A1 (es) | Combinaciones que comprenden un inhibidor del receptor del factor de crecimiento endotelial vascular |